Bay 65-1942 hydrochloride - ≥99% , CAS No.600734-06-3

CAS: 600734-06-3 Cat. No.: B649727 Formula: C22H26ClN3O4 Peso molecolare: 431.91 PubChem CID: 135454903
Disponibile su ordine
QUALITÀ & PUREZZA ≥99%
Synonyms
Bay 65-1942 (HCl salt),CAS:600734-06-3|KINK-1 hydrochloride|(-)-7-[2-(cyclopropylmethoxy)-6-hydroxy-phenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one hydrochloride|2H-Pyrido[2,3-d][1,3]oxazin-2-one, 7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-1,4-dihydro-5-[(3S)-3-piperidinyl]-, hydrochloride (1:1)|Bay 65-1942 HCl salt|KINK-1|(S)-7-(2-(Cyclopropylmethoxy)-6-hydroxyphenyl)-5-(piperidin-3-yl)-1H-pyrido(2,3-d)(1,3)oxazin-2(4H)-one hydrochloride|7-[2-(Cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido [2,3-d][1,3] oxazin-2-one Hydrochloride|2H-Pyrido(2,3-d)(1,3)oxazin-2-one, 7-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-1,4-dihydro-5-(3S)-3-piperidinyl-, monohydrochloride|7-(2-(Cyclopropylmethoxy)-6-hydroxyphenyl)-5-((3S)-3-piperidinyl)-1,4-dihydro-2H-pyrido(2,3-d)(1,3)oxazin-2-one hydrochloride|2H-Pyrido[2,3-d][1,3]oxazin-2-one, 7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-1,4-dihydro-5-(3S)-3-piperidinyl-, monohydrochloride|7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-piperidin-3-yl]-1,4-dihydropyrido[2,3-d][1,3]oxazin-2-one;hydrochloride|BAY65-1942|(S)-7-(2-(Cyclopropylmethoxy)-6-hydroxyphenyl)-5-(piperidin-3-yl)-1H-pyrido[2,3-d][1,3]oxazin-2(4H)-one hydrochloride|2H-Pyrido(2,3-d)(1,3)oxazin-2-one, 7-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-1,4-dihydro-5-((3S)-3-piperidinyl)-, hydrochloride (1:1)|7-[2-(Cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one hydrochloride|Bay 65-1942 (hydrochloride)|7-[2-(Cyclopropylmethoxy)-6-hydroxyphenyl]-1,4-dihydro-5-[(3S)-3-piperidinyl]-2H-pyrido[2,3-d][1,3]oxazin-2-one hydrochloride|Bay 65-1942 hydrochloride
Storage
Store at 2-8°C,Desiccated
Shipped In
Wet ice
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
2mg
B649727-2mg
Su ordinazione · 8–12 settimane
167,39€
5mg
B649727-5mg
Su ordinazione · 8–12 settimane
283,66€
10mg
B649727-10mg
Su ordinazione · 8–12 settimane
512,75€
25mg
B649727-25mg
Su ordinazione · 8–12 settimane
1.024,71€
50mg
B649727-50mg
Su ordinazione · 8–12 settimane
1.639,07€
100mg
B649727-100mg
Su ordinazione · 8–12 settimane
2.621,35€
Enter a quantity for the sizes you want to add.

Panoramica

Bay 65-1942 hydrochloride is an ATP-competitive and selective IKKβ inhibitor.

In Vitro

Delivery of Bay 65-1942 prior to ischemia significantly decreases left ventricular infarct size compared with animals receiving vehicle. Compared with sham animals, animals receiving vehicle have a significant increase in the infarct-to-area at risk (AAR) ratio (70.7±3.4 vs. 5.8±3.4%, P<0.05). This ratio is significantly reduced by treatment with Bay 65-1942 at each time point (prior to ischemia 42.7±4.1%, at reperfusion 42.7±7.5%, 2 h of reperfusion 29.4±5.2%; each group P<0.05 vs. vehicle). Animals pretreated with Bay 65-1942 (n=3) have significantly attenuated CK-MB levels compared with those animals without treatment prior to IR (14,170 ±3,219 units, P<0.05 vs. vehicle). MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Inhibitors of MEK (AZD6244) and IKK (BAY 65-1942) are used at their IC 50 concentrations, as determined by a 48 hour MTS assay, which achieve sufficient inhibition of kinase activity. MYL-R cells are treated for 24 hours with AZD6244 (5 µM), BAY 65-1942 (10 µM), or a combination of these inhibitors at the same concentrations. AZD6244 and BAY 65-1942 demonstrate synergistic inhibition of cell viability at the dose combination (5 µM AZD6244+10 µM BAY 65-1942), which correlates with IC 75 (CI = 0.48±0.01). Synergism is also indicated at the IC 50 (CI = 0.56±0.09) and IC 90 (CI = 0.46±0.02) dose combinations reported by the software (CI values are the mean of three independent experiments, ± standard deviation). AZD6244 and BAY 65-1942 treatment induces 2- and 1.3-fold caspase 3/7 activation, respectively, compared to the DMSO-treated cells. Treatment with a combination of AZD6244 plus BAY 65-1942 leads to a 3.2-fold increase in caspase 3/7 activity. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Assay

Cell viability is determined by seeding MYL-R cells on a 96-well plate at 4×10 4 cells/well in 100 µL RPMI growth medium supplemented with kinase inhibitors. Growth media and kinase inhibitors are replenished at 24 hours, and at 48 hours. 20 µL of MTS assay reagent is added to each well. The plate is returned to the incubator for approximately 1 hour and the absorbance at 490 nm is recorded. For combination index (CI) experiments, cells are grown and assayed. To determine AZD6244 and BAY 65-1942 (10 µM) dose-effects, cells are treated with a series of three-fold dilutions of each drug singly, or in combination while maintaining a constant ratio of 1:2, respectively. Cell viability results are analyzed to derive CI values. The CI values from three independent experiments are averaged. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Form:Solid

IC50& Target:IKKβ

Specifiche

Sinonimi
Bay 65-1942 (HCl salt),CAS:600734-06-3 | KINK-1 hydrochloride | (-)-7-[2-(cyclopropylmethoxy)-6-hydroxy-phenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one hydrochloride | 2H-Pyrido[2,3-d][1,3]oxazin-2-one, 7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-1,4-dihydro-5-[(3S)-3-piperidinyl]-, hydrochloride (1:1) | Bay 65 Mostra altro
Specifiche e purezza
≥99%
Meccanismi biochimici e fisiologici
Bay 65-1942 hydrochloride is an ATP-competitive and selective IKKβ inhibitor.
Condizioni di conservazione di stoccaggio
Store at 2-8°C,Desiccated
Spedito in
Wet ice
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Tipo di azione
INHIBITOR
Purezza
≥99%
Nomi e identificatori
SMILES
C1CC(CNC1)C2=CC(=NC3=C2COC(=O)N3)C4=C(C=CC=C4OCC5CC5)O.Cl
IUPAC Name
7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-piperidin-3-yl]-1,4-dihydropyrido[2,3-d][1,3]oxazin-2-one;hydrochloride
InChIKey
XZTOAEZYOFWVHB-PFEQFJNWSA-N
InChI
1S/C22H25N3O4.ClH/c26-18-4-1-5-19(28-11-13-6-7-13)20(18)17-9-15(14-3-2-8-23-10-14)16-12-29-22(27)25-21(16)24-17;/h1,4-5,9,13-14,23,26H,2-3,6-8,10-12H2,(H,24,25,27);1H/t14-;/m1./s1
Isomeri SMILES
C1C[C@H](CNC1)C2=CC(=NC3=C2COC(=O)N3)C4=C(C=CC=C4OCC5CC5)O.Cl
CAS alternativo
600734-06-3
PubChem CID
135454903
Termini MeSH
7-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-5-((3S)-3-piperidinyl)-1,4-dihydro-2H-pyrido(2,3-d)(1,3)oxazin-2-one hydrochloride
Peso molecolare
431.91

Dati avanzati

Struttura 3D
Modello di struttura chimica interattiva





Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Proprietà chimiche e fisiche
SolubilitàDMSO : 50 mg/mL (115.76 mM; Need ultrasonic) H2O : 2.17 mg/mL (5.02 mM; Need ultrasonic)
Peso molecolare431.9
XLogP3
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count6
Rotatable Bond Count5
Exact Mass431.161 Da
Monoisotopic Mass431.161 Da
Topological Polar Surface Area92.700 Ų
Heavy Atom Count30
Formal Charge0
Complexity586.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count2
Domande frequenti e articoli
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.